Psychoactive substances, users and markets: recent trends (2015-2016)
Tendances n° 115, OFDT, 8 p.
Since 1999, the Emerging Trends and New Drugs (TREND) scheme of the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has been monitoring recent and emerging phenomena in the field of drug use. This edition of Tendances summarises the main developments marking the sixteenth year of observation conducted by the network comprising seven sites (Bordeaux, Lille, Marseille, Metz, Paris, Rennes and Toulouse) extended to Lyon in 2016.
The first part, dedicated to the changing contexts and practices relating to substance use, touches on the recreational scene, strategic venues for certain types of substance use and the development of "chemsex" among part of the gay community. The analysis then focuses on the transformations in trafficking, marked by a rise in violence and the need for traffickers to seek out users who are increasingly reluctant to frequent traditional dealing sites. Lastly, the last part of this edition deals with the substances, particularly MDMA/ecstasy and its growing success, medications containing codeine and opioids (with the emergence of first-time users among individuals without a history of illicit drug use), crack and its expanding market in and beyond the Île-de-France region, and the still somewhat limited diffusion of new psychoactive substance (NPS) use.
Authors : Agnès Cadet-Taïrou, Michel Gandilhon, Magali Martinez, Thomas Néfau, Maitena Milhet
Download the PDF file (557 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2018 EMCDDA European Drug Report.
Country drug reports 2017
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.